Atherosclerosis is the underlying basis for the morbidity and death in about half of the American adult population. It is characterized by the progressive accumulation of cells, lipids, and extracellular matrix. Among the cells that accumulate in atherosclerotic plaques are cells of the immune system, in particular T cells and macrophages. This has led to the suggestion that inflammatory and immune mechanisms are involved in the development of atherosclerosis. This proposal is designed to address the question of the role of T cells and their gene products in this process. Apoprotein E (apoE) deficient mice are an immune competent mouse strain that spontaneously develops early as well as complex lesions throughout the aortic tree. These mice have been crossed with an immune incompetent mouse strain, recombination activating gene 2 deficient (RAG2) mice, that lack both t cells and B cells. The rate of development and progression or regression of atherosclerosis will be examined in these two mouse strains. The cellular and biochemical composition of the early fatty lesions and the more advanced lesions will be examined in detail. By adoptive transfer the role of individual T cell subtypes in lesion development and composition will be examined in the immune incompetent RAG2- apoE deficient mice. In addition, apoE or mutants of apoE will be expressed in the liver and specific arterial cells in order to examine the ability of these proteins to influence plasma lipids and lipoprotein profiles and the development and progression of atherosclerosis.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
1R01HL056827-01A1
Application #
2030224
Study Section
Pathology A Study Section (PTHA)
Project Start
1997-05-01
Project End
2002-04-30
Budget Start
1997-05-01
Budget End
1998-04-30
Support Year
1
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Chicago
Department
Pathology
Type
Schools of Medicine
DUNS #
225410919
City
Chicago
State
IL
Country
United States
Zip Code
60637
VanderLaan, Paul A; Reardon, Catherine A; Thisted, Ronald A et al. (2009) VLDL best predicts aortic root atherosclerosis in LDL receptor deficient mice. J Lipid Res 50:376-85
Getz, Godfrey S (2007) Overview of murine atherosclerosis series. Curr Drug Targets 8:1144-9
Wool, G D; Reardon, C A (2007) The influence of acute phase proteins on murine atherosclerosis. Curr Drug Targets 8:1203-14
VanderLaan, Paul A; Reardon, Catherine A; Sagiv, Yuval et al. (2007) Characterization of the natural killer T-cell response in an adoptive transfer model of atherosclerosis. Am J Pathol 170:1100-7
Reardon, Catherine A; Blachowicz, Lydia; Gupta, Gaorav et al. (2006) Site-specific influence of polyunsaturated fatty acids on atherosclerosis in immune incompetent LDL receptor deficient mice. Atherosclerosis 187:325-31
Getz, Godfrey S; Reardon, Catherine A (2006) Diet and murine atherosclerosis. Arterioscler Thromb Vasc Biol 26:242-9
Getz, Godfrey S (2005) Thematic review series: the immune system and atherogenesis. Immune function in atherogenesis. J Lipid Res 46:1-10
Reardon, Catherine A; Miller, Elizabeth R; Blachowicz, Lydia et al. (2004) Autoantibodies to OxLDL fail to alter the clearance of injected OxLDL in apolipoprotein E-deficient mice. J Lipid Res 45:1347-54
VanderLaan, Paul A; Reardon, Catherine A; Getz, Godfrey S (2004) Site specificity of atherosclerosis: site-selective responses to atherosclerotic modulators. Arterioscler Thromb Vasc Biol 24:12-22
Reardon, Catherine A; Blachowicz, Lydia; Lukens, John et al. (2003) Genetic background selectively influences innominate artery atherosclerosis: immune system deficiency as a probe. Arterioscler Thromb Vasc Biol 23:1449-54

Showing the most recent 10 out of 17 publications